Comparison of a 6‐month course peginterferon α‐2b plus ribavirin and interferon α‐2b plus ribavirin in treating Chinese patients with chronic hepatitis C in Taiwan
暂无分享,去创建一个
M. Lai | Y. Chao | T. Hsieh | P. Cheng | D. Chen | M. Yu | T.‐T. Chang | S. Lee | S. Hwang | W.-Y. Chang | C. Liu | T. Chang | S‐J. Hwang | W‐Y. Chang